The discovery and development of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) have had a major impact in the treatment of non small cell lung cancer (NSCLC). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.